Swertiamarin ameliorates cognitive dysfunction by improving hyperglycemia and neuroinflammation in type 2 diabetic rats via activation of the PI3K/AKT/GSK3β signaling pathway
Bingyin Tan, Li Liu, Tao Wu, Fangjie Yuan, Cheng Wang · 2024
Read Swertiamarin ameliorates cognitive dysfunction by improving hyperglycemia and neuroinflammation in type 2 diabetic rats via activation of the PI3K/AKT/GSK3β signaling pathway by Bingyin Tan, Li Liu, Tao Wu, Fangjie Yuan, Cheng Wang (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11811717.txt.
Description
Bingyin Tan and co-authors test a plant compound, swertiamarin, against the memory damage that diabetes causes in rats, in a 2024 study. Diabetes was induced with a fatty diet plus a chemical shot, then the compound was given and the rats faced a water maze. Blood sugar, insulin, brain tissue, and inflammation markers were measured.
Treated rats learned and remembered better, and their blood sugar and insulin fell. Brain sections showed less damage, less harmful tau build-up, and calmer inflammation in the memory center. A key signaling chain in the brain, dulled by diabetes, switched back on. The authors present the compound as a candidate worth further study for diabetic brain disease.
Catalog record
| CREATOR | Bingyin Tan, Li Liu, Tao Wu, Fangjie Yuan, Cheng Wang |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 23 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |